Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $72
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $75 to $72.
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $75 to $72.